Portal de Periódicos da CAPES

The Use of Systemic and Topical Fluoroquinolones

2016; American Academy of Pediatrics; Volume: 138; Issue: 5 Linguagem: Inglês

10.1542/peds.2016-2706

1098-4275

Mary Anne Jackson, Gordon E. Schutze,

Antimicrobial Resistance in Staphylococcus

Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy.